Corbus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,349 |
Gross Profit | -200 | -151 | 1,201 | |
EBITDA | -13,250 | -9,145 | -9,471 | -9,955 |
EBIT | -13,402 | -9,345 | -9,622 | -10,103 |
Net Income | -13,783 | -9,997 | -6,898 | -8,021 |
Net Change In Cash | 0 | 0 | 0 | 1,349 |
Free Cash Flow | -13,942 | -8,942 | -7,967 | -6,008 |
Cash | 19,423 | 23,971 | 14,388 | 13,916 |
Basic Shares | 12,014 | 2,812 | 2,812 | 4,423 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $881 | $3,937 |
Gross Profit | -31,167 | -1,487 | -757 | 3,838 |
EBITDA | -44,436 | -38,726 | -54,970 | -121,686 |
EBIT | -45,077 | -40,214 | -56,609 | -123,380 |
Net Income | -44,603 | -55,833 | -45,552 | -111,304 |
Net Change In Cash | 0 | 0 | 881 | 3,937 |
Cost of Revenue | 54,704 | |||
Free Cash Flow | -36,100 | -37,557 | -48,237 | -100,170 |
Cash | 13,916 | 17,002 | 25,006 | 85,433 |
Basic Shares | 4,327 | 4,170 | 4,099 | 2,604 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$1.15 |
2024-06-30 | -$0.90 |
2024-03-31 | -$0.83 |
2023-12-31 | -$1.81 |
